Advertisement

Institutional origins of health care–associated infection knowledge: Lessons from an analysis of articles about methicillin-resistant Staphylococcus aureus published in leading biomedical journals from 1960-2009

  • Fabio Rojas
    Correspondence
    Address correspondence to Fabio Rojas, PhD, Department of Sociology, Indiana University, Ballantine Hall 744, 1020 E Kirkwood Ave, Bloomington, IN 47405.
    Affiliations
    Department of Sociology, Indiana University, Bloomington, IL
    Search for articles by this author
  • W. Carson Byrd
    Affiliations
    Department of Pan-African Studies, University of Louisville, Louisville, KY
    Search for articles by this author
  • Sanjay Saint
    Affiliations
    Hospital Outcomes Program of Excellence, Department of Veterans Affairs, Ann Arbor Healthcare System, Ann Arbor, MI

    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI

    Department of Veterans Affairs/University of Michigan Patient Safety Enhancement Program, Ann Arbor, MI
    Search for articles by this author
Published:December 03, 2014DOI:https://doi.org/10.1016/j.ajic.2014.10.012

      Background

      Biomedical research journals are important because peer reviewed research is viewed as more legitimate and trustworthy than non-peer reviewed work. Therefore, it is important to know how knowledge transmitted through academic biomedical journals is produced. This article asks if some organizations are more likely to produce research than others and if organizational setting is linked with an article's impact, as measured by citation counts.

      Methods

      Using research on methicillin-resistant Staphylococcus aureus (MRSA) as a case study, we examined the role that hospitals, universities, public health agencies, and other organizations have in shaping an emerging research area. We collected public data on the organizational affiliations of researchers who authored 1,721 articles in general interest and selected specialty journals.

      Results

      MRSA research appears to have evolved in stages that require the participation of different types of organizations. Additionally, our analyses indicate that an author's organizational affiliation predicts citation counts, even when controlling for other factors.

      Conclusion

      Organizations vary greatly in their ability to produce research, and this should be taken into account by those who manage or award funds to research organizations.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Djulbegovic B.
        • Lacevic M.
        • Cantor A.
        • Fields K.K.
        • Bennett C.L.
        • Adams J.R.
        • et al.
        The uncertainty principle and industry-sponsored research.
        Lancet. 2000; 356: 635-663
        • Kjaergard L.L.
        • Als-Nielsen B.
        Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ.
        BMJ. 2002; 325: 249
        • Bekelman J.E.
        • Li Y.
        • Gross C.P.
        Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
        JAMA. 2003; 289: 454-465
        • Knorr-Cetina K.
        Epistemic cultures. How the sciences make knowledge.
        Harvard University Press, Cambridge1999
        • Wainwright S.P.
        • Williams C.
        • Michael M.
        • Farsides B.
        • Cribb A.
        From bench to bedside? Biomedical scientists' expectations of stem cell science as a future therapy for diabetes.
        Soc Sci Med. 2006; 63: 2052-2064
        • Smart A.
        • Tutton R.
        • Martin P.
        • Ellison G.T.
        • Ashcroft R.
        The standardization of race and ethnicity in biomedical science editorials and UK biobanks.
        Soc Stud Sci. 2008; 38: 407-423
        • Howard D.H.
        • Scott 2nd, R.D.
        • Packard R.
        • Jones D.
        The global impact of drug resistance.
        Clin Infect Dis. 2003; 36: S4-S10
        • Evans J.
        Industry induces academic science to know less about more.
        Am J Sociol. 2010; 116: 389-452
        • MacRae Jr., D.
        Growth and decay curves in scientific citations.
        Am Sociol Rev. 1969; 34: 631-635
        • Crane D.
        Invisible colleges. Diffusion of knowledge in scientific communities.
        University of Chicago Press, Chicago [IL]2010
        • Klevens R.M.
        • Morrison M.A.
        • Nadle J.
        • Petit S.
        • Gershman K.
        • Ray S.
        • et al.
        Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
        JAMA. 2007; 298: 1763-1771
        • Boucher H.W.
        • Corey G.R.
        Epidemiology of methicillin-resistant Staphylococcus aureus.
        Clin Infect Dis. 2008; 46: S344-S349
        • Roberts R.R.
        • Hota B.
        • Ahmad I.
        • Scott 2nd, R.D.
        • Foster S.D.
        • Abbasi F.
        • et al.
        Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.
        Clin Infect Dis. 2009; 49: 1175-1184
        • Archambault E.
        • Gagné E.V.
        The use of bibliometrics in social sciences and humanities.
        Social Sciences and Humanities Research Council of Canada, Montreal, Canada2004
        • McKenn M.
        Superbug: the fatal menace of MRSA.
        The Free Press, New York [NY]2010
      1. McKenna M. How much is drug resistant death worth? Less than $600. Available from: http://www.wired.com/wiredscience/2011/07/resistance-death-worth. Accessed June 5, 2012.

      2. Harzing A-W. Google Scholar - a new data source for citation analysis. Available from: http://www.harzing.com/pop_gs.htm. Accessed June 6, 2012.

        • Chubin D.E.
        The conceptualization of scientific specialties.
        Sociol Q. 1976; 17: 448-476
        • Cole J.R.
        • Zuckerman H.
        The emergence of a scientific specialty: the self-exemplifying case of the sociology of science.
        in: Coser L.A. The idea of a social structure: papers in honor of Robert K. Merton. Harcourt Brace Jovanovich, New York [NY]1975: 139-174
        • Fuchs S.
        A sociological theory of scientific change.
        Soc Forces. 1993; 71: 933-953
        • Morris S.A.
        • Van der Veer Martens B.
        Annual review of science and technology. Mapping research specialties.
        ARIST. 2008; 42: 213-295